Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 4/20 | 0.39 |
| ▸ | FAP | Q12884 | 2/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8296681 | 1.00 | XIAP (0.53) | XIAPPOLBKMT2AL3MBTL1DPP4 | |
| SCHEMBL5496665 | 0.90 | ELANE (0.46) | XIAPKMT2ADPP4DPP8DPP9 | |
| SCHEMBL30052896 | 0.87 | XIAP (0.64) | XIAPPOLBKMT2AL3MBTL1DPP4 | |
| SCHEMBL12658506 | 0.85 | DPP4 (0.57) | XIAPDPP4FAPDPP8DPP9 | |
| SCHEMBL30997482 | 0.82 | XIAP (0.52) | XIAPPOLBKMT2AL3MBTL1 | |
| SCHEMBL23071546 | 0.81 | XIAP (0.50) | XIAPPOLBKMT2AL3MBTL1DPP4 | |
| SCHEMBL2866462 | 0.81 | XIAP (0.50) | XIAPPOLBKMT2AL3MBTL1DPP4 | |
| SCHEMBL2863604 | 0.81 | XIAP (0.50) | XIAPPOLBKMT2AL3MBTL1DPP4 | |
| SCHEMBL2863596 | 0.81 | XIAP (0.50) | XIAPPOLBKMT2AL3MBTL1DPP4 | |
| SCHEMBL2866457 | 0.81 | XIAP (0.50) | XIAPPOLBKMT2AL3MBTL1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7166579-B2 | Prodrugs of DP IV-inhibitors | PROSIDION LIMITED (GB) | 2007-01-23 | — | — | US | claimed |